Tuesday, December 15, 2020

12:00PM ET/ 9:00 AM PT

KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen®


Yuri Fesko, MD
Medical Director of Oncology
Quest Diagnostics

Kari Hooper, MD
Pathologist, AmeriPath®/Quest Diagnostics Department Chair,
Integris Baptist Medical Center Oklahoma City, Oklahoma

Register  IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.